1. Home
  2. CPRX vs GSAT Comparison

CPRX vs GSAT Comparison

Compare CPRX & GSAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPRX
  • GSAT
  • Stock Information
  • Founded
  • CPRX 2002
  • GSAT 2003
  • Country
  • CPRX United States
  • GSAT United States
  • Employees
  • CPRX N/A
  • GSAT N/A
  • Industry
  • CPRX Biotechnology: Pharmaceutical Preparations
  • GSAT Telecommunications Equipment
  • Sector
  • CPRX Health Care
  • GSAT Consumer Discretionary
  • Exchange
  • CPRX Nasdaq
  • GSAT Nasdaq
  • Market Cap
  • CPRX 2.9B
  • GSAT 3.0B
  • IPO Year
  • CPRX 2006
  • GSAT 2006
  • Fundamental
  • Price
  • CPRX $23.37
  • GSAT $17.59
  • Analyst Decision
  • CPRX Strong Buy
  • GSAT Strong Buy
  • Analyst Count
  • CPRX 7
  • GSAT 3
  • Target Price
  • CPRX $32.29
  • GSAT $43.33
  • AVG Volume (30 Days)
  • CPRX 975.9K
  • GSAT 460.7K
  • Earning Date
  • CPRX 05-07-2025
  • GSAT 05-08-2025
  • Dividend Yield
  • CPRX N/A
  • GSAT N/A
  • EPS Growth
  • CPRX 178.13
  • GSAT N/A
  • EPS
  • CPRX 1.57
  • GSAT N/A
  • Revenue
  • CPRX $534,645,999.00
  • GSAT $253,901,000.00
  • Revenue This Year
  • CPRX $15.59
  • GSAT $7.69
  • Revenue Next Year
  • CPRX $8.90
  • GSAT $7.41
  • P/E Ratio
  • CPRX $14.90
  • GSAT N/A
  • Revenue Growth
  • CPRX 29.97
  • GSAT 14.55
  • 52 Week Low
  • CPRX $14.47
  • GSAT $15.00
  • 52 Week High
  • CPRX $26.16
  • GSAT $41.10
  • Technical
  • Relative Strength Index (RSI)
  • CPRX 50.33
  • GSAT 33.14
  • Support Level
  • CPRX $20.80
  • GSAT $19.51
  • Resistance Level
  • CPRX $25.01
  • GSAT $20.68
  • Average True Range (ATR)
  • CPRX 0.83
  • GSAT 0.77
  • MACD
  • CPRX -0.06
  • GSAT 0.01
  • Stochastic Oscillator
  • CPRX 61.05
  • GSAT 9.97

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).

About GSAT Globalstar Inc.

Globalstar Inc is a telecommunications company that derives revenue from the provision of mobile satellite services. Mobile satellite services are typically used by customers where existing terrestrial wireline and wireless communications networks are impaired or do not exist. The company provides communications services such as two-way voice and data transmission. In addition, one-way data transmission is also offered. Both services are offered using mobile or fixed devices. The company is an owner of satellite assets. The company generates the vast majority of its revenue within the United States.

Share on Social Networks: